Asliddin B. Nishonov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Asliddin B. Nishonov has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Roman Sergeevich Tarasov
Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово
11 shared publications - Leonid Semenovich Barbarash
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases
4 shared publications - Sergey Vasil'EVich Ivanov
Research Institute for Complex Issues of Cardiovascular Diseases
4 shared publications - Evgeniya Evgenievna Gorbatovskaya
Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical University of the Ministry of Health of the Russian Federation
3 shared publications - Olga V. Gruzdeva
Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Academician L.S. Barbarash Boulevard, 6, Kemerovo 650002, Russia
3 shared publications R.S. Tarasov
3 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (3) , 27-36
Association of sex and age with the ceramide profile of adipose tissue in patients with coronary artery disease
Background . Coronary artery disease (CAD) is associated with complex molecular changes in adipose tissue (AT) that go beyond simple energy storage. Current studies indicate the active participation of AT in metabolic regulation and secretion of bioactive lipid mediators, including ceramides, the role of which in CAD pathogenesis remains poorly understood, particularly with regard to age and sex differences. Aim. To characterize the ceramide profile in subcutaneous, epicardial and perivascular AT (SAT, EAT, PVAT) in patients with CAD, with regard to age and sex differences. Materials and Methods . A lipidomic study of the ceramide profile was conducted in SAT, EAT, PVAT samples obtained from 58 patients with CAD who underwent coronary artery bypass grafting (single-center prospective clinical study). The ceramide composition was analyzed by high-performance liquid chromatography with tandem mass spectrometric detection. Results . Ageand sex-related differences in the AT ceramide profile were identified. In men, the concentrations of cardionegative ceramides (Cer d18:1/14:0, Cer d18:1/18:0, Cer d18:1/20:0, Cer d18:1/22:0) and Cer d18:1/24:1 were higher (p < 0.05). In PVAT of men, the levels of Cer 14:0, 16:0 and 22:4 were increased (p < 0.001). In EAT and PVAT of women, increased levels of Cer 18:0 and 23:0 were noted (p < 0.05). In EAT and PAT of women, the concentrations of Cer 20:0, 22:0 and 24:1 were higher (p < 0.05). The highest levels of cardionegative ceramides were observed in PVAT of patients aged over 75 years. The ratio of cardionegative to cardioprotective ceramides was higher in EAT in individuals aged 60–74 years and in PVAT in those aged over 75 years. Conclusion. Significant sexand age-related differences in the AT ceramide profile of patients with CAD were identified, emphasizing the need to consider these factors when assessing cardiovascular risk. The data obtained may contribute to the development of new therapeutic strategies aimed at modulating the ceramide profile of AT to reduce cardiovascular risk.
- 2 August 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (3) , 27-36
Open AccessAssociation of sex and age with the ceramide profile of adipose tissue in patients with coronary artery disease
Background . Coronary artery disease (CAD) is associated with complex molecular changes in adipose tissue (AT) that go beyond simple energy storage. Current studies indicate the active participation of AT in metabolic regulation and secretion of bioactive lipid mediators, including ceramides, the role of which in CAD pathogenesis remains poorly understood, particularly with regard to age and sex differences. Aim. To characterize the ceramide profile in subcutaneous, epicardial and perivascular AT (SAT, EAT, PVAT) in patients with CAD, with regard to age and sex differences. Materials and Methods . A lipidomic study of the ceramide profile was conducted in SAT, EAT, PVAT samples obtained from 58 patients with CAD who underwent coronary artery bypass grafting (single-center prospective clinical study). The ceramide composition was analyzed by high-performance liquid chromatography with tandem mass spectrometric detection. Results . Ageand sex-related differences in the AT ceramide profile were identified. In men, the concentrations of cardionegative ceramides (Cer d18:1/14:0, Cer d18:1/18:0, Cer d18:1/20:0, Cer d18:1/22:0) and Cer d18:1/24:1 were higher (p < 0.05). In PVAT of men, the levels of Cer 14:0, 16:0 and 22:4 were increased (p < 0.001). In EAT and PVAT of women, increased levels of Cer 18:0 and 23:0 were noted (p < 0.05). In EAT and PAT of women, the concentrations of Cer 20:0, 22:0 and 24:1 were higher (p < 0.05). The highest levels of cardionegative ceramides were observed in PVAT of patients aged over 75 years. The ratio of cardionegative to cardioprotective ceramides was higher in EAT in individuals aged 60–74 years and in PVAT in those aged over 75 years. Conclusion. Significant sexand age-related differences in the AT ceramide profile of patients with CAD were identified, emphasizing the need to consider these factors when assessing cardiovascular risk. The data obtained may contribute to the development of new therapeutic strategies aimed at modulating the ceramide profile of AT to reduce cardiovascular risk.
- Open Access
Mesenchymal Stem Cells of Epicardial Adipose Tissue Show Differences in Immunophenotype and Osteogenic Potential in Patients with Coronary and Non-Coronary Heart Disease
Coronary artery calcification (CAC) is a pressing issue in cardiology. Mesenchymal stem cells (MSCs) derived from epicardial adipose tissue (EAT) may serve as a source of osteoblasts in the cardiovascular system. This study aimed to evaluate and compare the immunophenotype, proliferation, and osteogenic potential of EAT-MSCs from patients with coronary artery disease (CAD) and those with aortic stenosis (AS). The immunophenotype of MSCs was analyzed based on key markers: CD105, CD90, CD73, CD31, CD34, CD45, HLA-DR. Cell proliferation was assessed by the doubling time of the population and the specific growth rate of the cultures. The osteogenic potential was evaluated by the expression levels of the RUNX2, SPP1, ALPL, and BGLAP genes using PCR, as well as the protein levels in supernatants via ELISA. Qualitative detection of osteogenic proteins in cells by immunofluorescence staining. The intensity of extracellular matrix mineralization was measured using photometric methods. CD73 expression in EAT-MSCs from CAD patients was nearly 50% lower than in EAT-MSC cultures from AS patients. Following osteogenic induction, EAT-MSCs from CAD patients showed increased expression of osteogenic marker genes and their corresponding proteins. The intensity of extracellular matrix mineralization by osteoblasts derived from EAT-MSCs of CAD patients was higher than in the comparison group. EAT-MSCs from CAD patients with coronary calcification demonstrated reduced CD73 expression in culture and enhanced osteogenic potential compared to patients without coronary artery involvement.
Open AccessMesenchymal Stem Cells of Epicardial Adipose Tissue Show Differences in Immunophenotype and Osteogenic Potential in Patients with Coronary and Non-Coronary Heart Disease
Coronary artery calcification (CAC) is a pressing issue in cardiology. Mesenchymal stem cells (MSCs) derived from epicardial adipose tissue (EAT) may serve as a source of osteoblasts in the cardiovascular system. This study aimed to evaluate and compare the immunophenotype, proliferation, and osteogenic potential of EAT-MSCs from patients with coronary artery disease (CAD) and those with aortic stenosis (AS). The immunophenotype of MSCs was analyzed based on key markers: CD105, CD90, CD73, CD31, CD34, CD45, HLA-DR. Cell proliferation was assessed by the doubling time of the population and the specific growth rate of the cultures. The osteogenic potential was evaluated by the expression levels of the RUNX2, SPP1, ALPL, and BGLAP genes using PCR, as well as the protein levels in supernatants via ELISA. Qualitative detection of osteogenic proteins in cells by immunofluorescence staining. The intensity of extracellular matrix mineralization was measured using photometric methods. CD73 expression in EAT-MSCs from CAD patients was nearly 50% lower than in EAT-MSC cultures from AS patients. Following osteogenic induction, EAT-MSCs from CAD patients showed increased expression of osteogenic marker genes and their corresponding proteins. The intensity of extracellular matrix mineralization by osteoblasts derived from EAT-MSCs of CAD patients was higher than in the comparison group. EAT-MSCs from CAD patients with coronary calcification demonstrated reduced CD73 expression in culture and enhanced osteogenic potential compared to patients without coronary artery involvement.
- Open Access
- 29 June 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (3) , 190-198
IN-HOSPITAL OUTCOMES OF MINIMALLY INVASIVE CORONARY ARTERY BYPASS GRAFTING
Highlights Modern cardiac surgery techniques are designed to minimize intervention in stenting, allowing these procedures to be performed on a wider range of patients. In this regard, the intra- and postoperative aspects of minimally invasive coronary artery bypass grafting (MICABG) are of interest, demonstrating the advantages of this procedure. Background. Minimally invasive coronary artery bypass grafting (MIDCABG) reduces surgical trauma in patients with coronary artery disease, especially when complete myocardial revascularization is not possible. However, technical difficulties can impact the quality of the mammary coronary anastomosis, resulting in dysfunction of the most important bypass graft in coronary surgery. Aim . To analyze the in-hospital outcomes of mammary coronary artery bypass grafting using lateral minithoracotomy. Methods . A total of 72 cases of minimally invasive coronary artery bypass grafting via lateral minithoracotomy (MIDCAB) were selected in 2025 (Group I) using a continuous sampling method. A comparison group of 67 cases of isolated mammary coronary artery bypass grafting via median sternotomy was selected using a continuous sampling method in 2021–2025 (Group II). Clinical, demographic, and intraoperative data, as well as in-hospital outcomes, were analyzed. Results. According to the main clinical and demographic data, the patients were comparable. The mean age was 64.9 ± 7.2 and 67 ± 5 years (p = 0.1). The main cohort of patients consisted of patients with angina pectoris of functional class I–II (90.3% and 81%, p = 0.4), functional class III–IV was noted in 8.3% and 12% of patients, the remaining patients had acute coronary syndrome (1.4% versus 7%, p = 0.08). Multivessel disease was statistically significantly more common in patients with median sternotomy (36.1% versus 52.2%, p = 0.045). The left ventricular ejection fraction was significantly lower in the sternotomy group (61.6 ± 5.7 versus 57.1 ± 10.6, p = 0.01). In the MIDCAB group, the operative time was significantly shorter (119 ± 19 vs. 129.8 ± 23 minutes, p = 0.04), and the diameter of the installed intracoronary bypass graft was significantly smaller (1.6 ± 0.2 vs. 1.8 ± 0.2, p = 0.0001). There was no in-hospital mortality in the groups, 1 (1.4%) perioperative myocardial infarction was noted in the MIDCAB group, and 1 case of acute cerebrovascular accident in the sternotomy group. No significant differences were found in the aspect of the development of major cardiovascular catastrophes (1.4% vs. 3%, p = 0.5). The duration of postoperative hospital stay was statistically significantly shorter in the MIDCAB group (9 ± 2 vs. 11 ± 3 days, p = 0.004). Conclusions. Mammary coronary artery bypass grafting from lateral minithoracotomy is a safe and effective method of myocardial revascularization, including in patients with multivessel coronary disease, in whom complete myocardial revascularization is impossible.
- 29 June 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (3) , 190-198
Open AccessIN-HOSPITAL OUTCOMES OF MINIMALLY INVASIVE CORONARY ARTERY BYPASS GRAFTING
Highlights Modern cardiac surgery techniques are designed to minimize intervention in stenting, allowing these procedures to be performed on a wider range of patients. In this regard, the intra- and postoperative aspects of minimally invasive coronary artery bypass grafting (MICABG) are of interest, demonstrating the advantages of this procedure. Background. Minimally invasive coronary artery bypass grafting (MIDCABG) reduces surgical trauma in patients with coronary artery disease, especially when complete myocardial revascularization is not possible. However, technical difficulties can impact the quality of the mammary coronary anastomosis, resulting in dysfunction of the most important bypass graft in coronary surgery. Aim . To analyze the in-hospital outcomes of mammary coronary artery bypass grafting using lateral minithoracotomy. Methods . A total of 72 cases of minimally invasive coronary artery bypass grafting via lateral minithoracotomy (MIDCAB) were selected in 2025 (Group I) using a continuous sampling method. A comparison group of 67 cases of isolated mammary coronary artery bypass grafting via median sternotomy was selected using a continuous sampling method in 2021–2025 (Group II). Clinical, demographic, and intraoperative data, as well as in-hospital outcomes, were analyzed. Results. According to the main clinical and demographic data, the patients were comparable. The mean age was 64.9 ± 7.2 and 67 ± 5 years (p = 0.1). The main cohort of patients consisted of patients with angina pectoris of functional class I–II (90.3% and 81%, p = 0.4), functional class III–IV was noted in 8.3% and 12% of patients, the remaining patients had acute coronary syndrome (1.4% versus 7%, p = 0.08). Multivessel disease was statistically significantly more common in patients with median sternotomy (36.1% versus 52.2%, p = 0.045). The left ventricular ejection fraction was significantly lower in the sternotomy group (61.6 ± 5.7 versus 57.1 ± 10.6, p = 0.01). In the MIDCAB group, the operative time was significantly shorter (119 ± 19 vs. 129.8 ± 23 minutes, p = 0.04), and the diameter of the installed intracoronary bypass graft was significantly smaller (1.6 ± 0.2 vs. 1.8 ± 0.2, p = 0.0001). There was no in-hospital mortality in the groups, 1 (1.4%) perioperative myocardial infarction was noted in the MIDCAB group, and 1 case of acute cerebrovascular accident in the sternotomy group. No significant differences were found in the aspect of the development of major cardiovascular catastrophes (1.4% vs. 3%, p = 0.5). The duration of postoperative hospital stay was statistically significantly shorter in the MIDCAB group (9 ± 2 vs. 11 ± 3 days, p = 0.004). Conclusions. Mammary coronary artery bypass grafting from lateral minithoracotomy is a safe and effective method of myocardial revascularization, including in patients with multivessel coronary disease, in whom complete myocardial revascularization is impossible.
- Open Access
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 5-14
Endothelial cells of arterial and venous blood in patients with various forms of coronary heart disease as a possible indicator of sustainability the morphofunctional system of the conduit artery
Aim. To conduct an assessment of the quantity, qualitative composition, and proliferative potential of blood ECs taken from the coronary artery (CA), internal mammary artery (IMA), radial artery (RA), and venous bed in patients with ASC and IHD. Materials and methods. The study examined eight biological blood samples obtained from two male patients: a 72-year-old with ACS and a 63-year-old with stable IHD. Each patient had 20 ml of venous blood obtained from the cubital vein and 20 ml of arterial blood obtained from the internal thoracic, radial, and coronary arteries. The mononuclear fraction was isolated from the blood, the cells were counted, cultured in vitro. Results. During 26 days of cultivation, cells in the vials were counted. The highest proliferative activity of ECFC was observed in a patient with ACS: the doubling time of the population was 2.17 days for cells isolated from blood of CA and 2.38 days for cells isolated from blood of IMA. In a patient with chronic IHD, the doubling time of ECFC cells obtained from venous blood was higher – 2.54 days. The highest concentration of ECFC was detected in a patient with ACS in the blood of the infarct-related artery. Conclusion. An analysis of endothelial cells isolated from the blood of CA and conductive vessels in CS revealed differences depending on the form of IHD. In patients with ACS, similarities in the characteristics and growth of CA and IMA ECs were noted, which may reflect the unidirectionality of reparative processes and increased stability of the MFS of conduit arteries when using these autoarterial grafts.
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 5-14
Open AccessEndothelial cells of arterial and venous blood in patients with various forms of coronary heart disease as a possible indicator of sustainability the morphofunctional system of the conduit artery
Aim. To conduct an assessment of the quantity, qualitative composition, and proliferative potential of blood ECs taken from the coronary artery (CA), internal mammary artery (IMA), radial artery (RA), and venous bed in patients with ASC and IHD. Materials and methods. The study examined eight biological blood samples obtained from two male patients: a 72-year-old with ACS and a 63-year-old with stable IHD. Each patient had 20 ml of venous blood obtained from the cubital vein and 20 ml of arterial blood obtained from the internal thoracic, radial, and coronary arteries. The mononuclear fraction was isolated from the blood, the cells were counted, cultured in vitro. Results. During 26 days of cultivation, cells in the vials were counted. The highest proliferative activity of ECFC was observed in a patient with ACS: the doubling time of the population was 2.17 days for cells isolated from blood of CA and 2.38 days for cells isolated from blood of IMA. In a patient with chronic IHD, the doubling time of ECFC cells obtained from venous blood was higher – 2.54 days. The highest concentration of ECFC was detected in a patient with ACS in the blood of the infarct-related artery. Conclusion. An analysis of endothelial cells isolated from the blood of CA and conductive vessels in CS revealed differences depending on the form of IHD. In patients with ACS, similarities in the characteristics and growth of CA and IMA ECs were noted, which may reflect the unidirectionality of reparative processes and increased stability of the MFS of conduit arteries when using these autoarterial grafts.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6)
EXPRESSION OF ADIPONECTIN AND ITS RECEPTORS IN ADIPOSE TISSUE OF EPICARDIAL AND PERICORONARY LOCALIZATION OF PATIENTS WITH CARDIOVASCULAR DISEASES
Highlights Numerous studies support the role of adiponectin (AN) in the pathophysiology of the cardiovascular system (CVS). Clinical data indicate an association of low serum AN level with coronary artery disease (CAD) and an increased risk of atherosclerosis. The lack of data on the expression of high-molecular-weight adiponectin (HMW-ADPN) and its receptors in epicardial adipose tissue (EAT) and pericoronary adipose tissue (PCAT) highlights the need for further research to understand their role in the development of cardiovascular diseases (CVD). Aim. To evaluate the expression features of total adiponectin (ADPN), high-molecular-weight adiponectin (HMW-ADPN) and its receptors in epicardial adipose tissue (EAT) and pericoronary adipose tissue (PCAT) of patients with cardiovascular diseases (CVD). Methods. The study included 156 patients with stable coronary artery disease and 120 patients with degenerative non-rheumatic valvular heart disease. Patients in the study groups were matched for gender, age, and body mass index. During surgery, 3–5 g samples of subcutaneous, epicardial, and pericoronary AT (SAT, EAT, and PCAT) were obtained. Adiponectin gene expression (ADIPOQ) was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Total ADPN, HMW-ADPN, and ADPN receptor concentrations were determined by enzyme immunoassay according to the manufacturers’ protocols. Statistical analysis was performed using GraphPad Prism 8 and Statistica 12.0. Results. Patients with coronary atherosclerosis had low ADIPOQ mRNA levels, low total ADPN and AdipoR1 receptor levels in EAT adipocyte cultures compared to SAT adipocytes and the acquired heart defects (AHD) group. The levels of HMW-ADPN and AdipoR2 were minimal in both EAT and PCAT adipocyte cultures, which were higher among individuals with ADP. Severe and extremely severe coronary artery disease was associated with low ADIPOQ mRNA expression and low HMW-ADPN levels in EAT and PCAT and AdipoR2 deficiency in EAT. Conclusion. Coronary atherosclerosis is characterized by the presence of HMW-ADPN and ADPN receptor deficiency not only in EAT adipocytes but also in PCAT adipocytes. A decrease in the level of HMW-ADPN secretion in adipocytes of EAT and PCAT and the expression of AdipoR2 in EAT is associated with more severe coronary artery disease.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6)
EXPRESSION OF ADIPONECTIN AND ITS RECEPTORS IN ADIPOSE TISSUE OF EPICARDIAL AND PERICORONARY LOCALIZATION OF PATIENTS WITH CARDIOVASCULAR DISEASES
Highlights Numerous studies support the role of adiponectin (AN) in the pathophysiology of the cardiovascular system (CVS). Clinical data indicate an association of low serum AN level with coronary artery disease (CAD) and an increased risk of atherosclerosis. The lack of data on the expression of high-molecular-weight adiponectin (HMW-ADPN) and its receptors in epicardial adipose tissue (EAT) and pericoronary adipose tissue (PCAT) highlights the need for further research to understand their role in the development of cardiovascular diseases (CVD). Aim. To evaluate the expression features of total adiponectin (ADPN), high-molecular-weight adiponectin (HMW-ADPN) and its receptors in epicardial adipose tissue (EAT) and pericoronary adipose tissue (PCAT) of patients with cardiovascular diseases (CVD). Methods. The study included 156 patients with stable coronary artery disease and 120 patients with degenerative non-rheumatic valvular heart disease. Patients in the study groups were matched for gender, age, and body mass index. During surgery, 3–5 g samples of subcutaneous, epicardial, and pericoronary AT (SAT, EAT, and PCAT) were obtained. Adiponectin gene expression (ADIPOQ) was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Total ADPN, HMW-ADPN, and ADPN receptor concentrations were determined by enzyme immunoassay according to the manufacturers’ protocols. Statistical analysis was performed using GraphPad Prism 8 and Statistica 12.0. Results. Patients with coronary atherosclerosis had low ADIPOQ mRNA levels, low total ADPN and AdipoR1 receptor levels in EAT adipocyte cultures compared to SAT adipocytes and the acquired heart defects (AHD) group. The levels of HMW-ADPN and AdipoR2 were minimal in both EAT and PCAT adipocyte cultures, which were higher among individuals with ADP. Severe and extremely severe coronary artery disease was associated with low ADIPOQ mRNA expression and low HMW-ADPN levels in EAT and PCAT and AdipoR2 deficiency in EAT. Conclusion. Coronary atherosclerosis is characterized by the presence of HMW-ADPN and ADPN receptor deficiency not only in EAT adipocytes but also in PCAT adipocytes. A decrease in the level of HMW-ADPN secretion in adipocytes of EAT and PCAT and the expression of AdipoR2 in EAT is associated with more severe coronary artery disease.
- Open Access
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 133-139
AUTOGENOUS ARTERIAL REVASCULARIZATION FOR NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN A HIGH-RISK PATIENT
HighlightsPerforming emergency coronary artery bypass grafting in patients with high-risk acute coronary syndrome without ST segment elevation and accumulating experience with these interventions will help specialists to implement open myocardial revascularization into clinical practice as a self-sufficient treatment modality. AbstractThe presented clinical case demonstrates the possibility of performing complete myocardial revascularization by means of total autogenous arterial revascularization in high-risk non-ST-segment elevation acute coronary syndrome and multivessel coronary disease within the framework of the aortic no-touch technique in case of total calcification of the ascending aorta.
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 133-139
Open AccessAUTOGENOUS ARTERIAL REVASCULARIZATION FOR NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN A HIGH-RISK PATIENT
HighlightsPerforming emergency coronary artery bypass grafting in patients with high-risk acute coronary syndrome without ST segment elevation and accumulating experience with these interventions will help specialists to implement open myocardial revascularization into clinical practice as a self-sufficient treatment modality. AbstractThe presented clinical case demonstrates the possibility of performing complete myocardial revascularization by means of total autogenous arterial revascularization in high-risk non-ST-segment elevation acute coronary syndrome and multivessel coronary disease within the framework of the aortic no-touch technique in case of total calcification of the ascending aorta.
- Open Access
- 1 January 2025
- Published by A.V. Vishnevsky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation in Minimally Invasive Cardiovascular Surgery
- Vol. 1 (1) , 77-83
A CLINICAL CASE OF NON-STANDARD EXPLANTATION OF INFECTED PACER ELECTRODES IN A PATIENT WITH A HISTORY OF CABG
Цель: изучение электрод-ассоциированной инфекции и обоснование эксплантации электродов ЭКС через миниторакотомию под рентгенконтролем у пациента с многократной хирургической обработкой ложа ЭКС и АКШ в анамнезе. Материалы и методы: клинический случай оперативного вмешательства в объеме эксплантации инфицированных электродов через правостороннюю миниторакотомию под рентген-контролем на базе НИИ КПССЗ г. Кемерово. Результаты: оперативное вмешательство, проведенное на базе НИИ КПССЗ г. Кемерово, в объеме эксплантации электродов через правостороннюю миниторакотомию под рентген-контролем позволило полностью элиминировать источник инфекции, не поддающийся медикаментозной терапии. Хирургический доступ снизил риск интра- и послеоперационных осложнений и сократил реабилитационный период пациента. Заключение: выбор тактики оперативного вмешательства носит индивидуальный подход для каждого пациента. В данном клиническом случае малоинвазивный доступ в объеме миниторакотомии позволил не только успешно выполнить операцию, но и сократил возможные осложнения.
- 1 January 2025
- Published by A.V. Vishnevsky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation in Minimally Invasive Cardiovascular Surgery
- Vol. 1 (1) , 77-83
Open AccessA CLINICAL CASE OF NON-STANDARD EXPLANTATION OF INFECTED PACER ELECTRODES IN A PATIENT WITH A HISTORY OF CABG
Цель: изучение электрод-ассоциированной инфекции и обоснование эксплантации электродов ЭКС через миниторакотомию под рентгенконтролем у пациента с многократной хирургической обработкой ложа ЭКС и АКШ в анамнезе. Материалы и методы: клинический случай оперативного вмешательства в объеме эксплантации инфицированных электродов через правостороннюю миниторакотомию под рентген-контролем на базе НИИ КПССЗ г. Кемерово. Результаты: оперативное вмешательство, проведенное на базе НИИ КПССЗ г. Кемерово, в объеме эксплантации электродов через правостороннюю миниторакотомию под рентген-контролем позволило полностью элиминировать источник инфекции, не поддающийся медикаментозной терапии. Хирургический доступ снизил риск интра- и послеоперационных осложнений и сократил реабилитационный период пациента. Заключение: выбор тактики оперативного вмешательства носит индивидуальный подход для каждого пациента. В данном клиническом случае малоинвазивный доступ в объеме миниторакотомии позволил не только успешно выполнить операцию, но и сократил возможные осложнения.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 13 (2)
Coronary artery bypass grafting for high-risk acute non-ST elevation coronary syndrome in men and women
Результаты коронарного шунтирования при остром коронарном синдроме без подъема сегмента ST высокого риска у мужчин и женщин
- 1 January 2025
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 13 (2)
Open AccessCoronary artery bypass grafting for high-risk acute non-ST elevation coronary syndrome in men and women
Результаты коронарного шунтирования при остром коронарном синдроме без подъема сегмента ST высокого риска у мужчин и женщин
- Open Access
- 31 March 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (1) , 151-159
Outcomes of coronary artery bypass grafting and percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes
Highlights. Despite high hospital mortality after coronary bypass grafting in patients with high-risk non–STsegment elevation acute coronary syndrome, surgical myocardial revascularization remains a preferable treatment modality since percutaneous coronary intervention in these patients is associated with high perioperative complications due to severely calcified coronary lesions.Background. The optimal revascularization strategy in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains the subject of many years of controversy. Coronary artery bypass grafting (CABG) improves the long-term prognosis through complete revascularization, however, percutaneous coronary intervention (PCI), due to its availability and low invasiveness, suggests an improvement in hospital outcomes.Aim. To compare hospital outcomes of CABG and PCI performed within 24 hours in high-risk NSTE-ACS patients.Methods. In the present study, the first group included 30 NSTE-ACS patients who underwent CABG in the first 24 hours (the CABG group), whereas 30 NSTE-ACS patients who underwent PCI were included in the second group (the PCI group).Results. The mean age was 64,4±7,3 years, it was comparable in both groups. The main clinical and anamnestic characteristics of patient in both groups were comparable as well. The severity of coronary atherosclerosis according to the Syntax score was 25,6±9,2 in the CABG group, and 21,7±5,7 in the PCI group (p = 0,054). After revascularization, the residual Syntax score did not differ between the groups (p = 0,42), indicating complete revascularization. Hospital mortality was relatively high in the CABG group (13,3%), while no such cases were noted in the PCI group. Most of the patients with adverse outcomes had a critical lesion of the left main coronary artery and a complicated postoperative course.Conclusion. The results of this study demonstrate promising outcome of CABG in patients with severe multivessel coronary disease at high risk of adverse events.
- 31 March 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (1) , 151-159
Open AccessOutcomes of coronary artery bypass grafting and percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes
Highlights. Despite high hospital mortality after coronary bypass grafting in patients with high-risk non–STsegment elevation acute coronary syndrome, surgical myocardial revascularization remains a preferable treatment modality since percutaneous coronary intervention in these patients is associated with high perioperative complications due to severely calcified coronary lesions.Background. The optimal revascularization strategy in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains the subject of many years of controversy. Coronary artery bypass grafting (CABG) improves the long-term prognosis through complete revascularization, however, percutaneous coronary intervention (PCI), due to its availability and low invasiveness, suggests an improvement in hospital outcomes.Aim. To compare hospital outcomes of CABG and PCI performed within 24 hours in high-risk NSTE-ACS patients.Methods. In the present study, the first group included 30 NSTE-ACS patients who underwent CABG in the first 24 hours (the CABG group), whereas 30 NSTE-ACS patients who underwent PCI were included in the second group (the PCI group).Results. The mean age was 64,4±7,3 years, it was comparable in both groups. The main clinical and anamnestic characteristics of patient in both groups were comparable as well. The severity of coronary atherosclerosis according to the Syntax score was 25,6±9,2 in the CABG group, and 21,7±5,7 in the PCI group (p = 0,054). After revascularization, the residual Syntax score did not differ between the groups (p = 0,42), indicating complete revascularization. Hospital mortality was relatively high in the CABG group (13,3%), while no such cases were noted in the PCI group. Most of the patients with adverse outcomes had a critical lesion of the left main coronary artery and a complicated postoperative course.Conclusion. The results of this study demonstrate promising outcome of CABG in patients with severe multivessel coronary disease at high risk of adverse events.